Gut microbiome may shape response to GLP-1 drugs, new review suggests

https://www.news-medical.net/news/20260219/Gut-microbiome-may-shape-response-to-GLP-1-drugs-new-review-suggests.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=pharmacy_and_pharmacology_newsletter_27_february_2026 Emerging evidence suggests that microbial metabolites not only regulate endogenous GLP-1 secretion but may also influence therapeutic response to GLP-1 receptor agonists, raising the prospect of microbiome-guided treatment strategies in obesity and type 2 diabetes.